NASDAQ: MURA
Mural Oncology PLC Stock Ownership - Who owns Mural Oncology?

Insider buying vs selling

Have Mural Oncology PLC insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Maiken KesonbrookesChief Legal Officer and Secretary2025-07-222,572$2.48
$6.38kSell
Maiken KesonbrookesChief Legal Officer and Secretary2025-07-182,158$2.48
$5.35kSell
Caroline LoewChief Executive Officer2025-07-0712,531$2.43
$30.48kSell
Maiken KesonbrookesChief Legal Officer and Secretary2025-03-051,469$3.45
$5.07kSell
Maiken KesonbrookesChief Legal Officer and Secretary2025-03-041,262$3.36
$4.24kSell
Caroline LoewChief Executive Officer2025-03-044,313$3.36
$14.49kSell
Vicki L. GoodmanChief Medical Officer2025-02-2413,186$3.89
$51.29kSell
Maiken KesonbrookesChief Legal Officer and Secretary2024-12-232,555$3.27
$8.35kSell
Caroline LoewChief Executive Officer2024-12-172,763$3.40
$9.39kSell
Vicki L. GoodmanChief Medical Officer2024-11-075,069$3.33
$16.88kSell

1 of 2

MURA insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when MURA insiders and whales buy or sell their stock.

MURA Shareholders

What type of owners hold Mural Oncology PLC stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Soleus Capital Management LP7.64%1,323,877$2.73MInstitution
Prosight Management LP5.19%900,000$1.85MInstitution
Vanguard Group Inc4.46%772,851$1.59MInstitution
Acorn Capital Advisors LLC3.77%653,779$1.35MInstitution
Orbimed Advisors LLC3.40%588,800$1.21MInstitution
Newtyn Management LLC3.29%570,000$1.17MInstitution
Lmr Partners LLP2.98%516,417$1.06MInstitution
Diametric Capital LP2.02%350,000$721.00kInstitution
Millennium Management LLC1.82%316,040$651.04kInstitution
Caroline Loew1.69%293,059$603.70kInsider

1 of 3

MURA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
MURA47.53%3.28%Net SellingNet Selling
RADX0.02%0.00%
CASI2.75%97.25%
ESLA1.71%80.01%
IGC3.35%22.33%Net Buying

Mural Oncology Stock Ownership FAQ

Who owns Mural Oncology?

Mural Oncology (NASDAQ: MURA) is owned by 47.53% institutional shareholders, 3.28% Mural Oncology insiders, and 49.19% retail investors. Caroline Loew is the largest individual Mural Oncology shareholder, owning 293,059.00 shares representing 1.69% of the company. Caroline Loew's Mural Oncology shares are currently valued at $603.70k.

If you're new to stock investing, here's how to buy Mural Oncology stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.